The Bridge program was launched in 2017 to help researchers and life science entrepreneurs to connect with industry leaders in the Australian biotech ecosystem.
The official program launch was on the 12th of April 2022 in Sydney. Dr Tayner Rodriguez is participating in the 2022 Bridge Program and will join members of the global pharmaceutical industry to share peer-knowledge, problem-based learning and case-based examples allowing workplace application, helping identify and employ managerial skills for research commercialisation.
A three-day Symposium at the Gold Coast Convention Centre promoting networking with the alumni community of over 700 industry professionals will take place in June 2022.
